A possible reason might be that patients with CHD may be more likely to produce Ubiquitin carboxyl-terminal esterase L1 (UCHL1) due to myocardial damage, and UCHL1 plays a vital role in the deubiquitination and stabilization of α-synuclein (Wilkinson et al., 1989). Here, SNCA is linked to coronary artery disorder.